Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Page 1
Thrombocytopenia with and without thrombosis following COVID-19 vaccination: long-term management.
Ge M, Ladha D, Lymer J, Pancic S, Carrier M, Le Gal G, Castellucci LA. Ge M, et al. Among authors: le gal g. Res Pract Thromb Haemost. 2024 Mar 1;8(2):102357. doi: 10.1016/j.rpth.2024.102357. eCollection 2024 Feb. Res Pract Thromb Haemost. 2024. PMID: 38550529 Free PMC article.
BACKGROUND: Since administration of COVID-19 vaccines, there has been growing evidence of thrombotic and thrombocytopenic events following vaccination. However, there remains limited data on long-term management of these adverse hematologic events. KEY CLINICAL QUESTION: W …
BACKGROUND: Since administration of COVID-19 vaccines, there has been growing evidence of thrombotic and thrombocytopenic events following v …
Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis.
van Es N, Takada T, Kraaijpoel N, Klok FA, Stals MAM, Büller HR, Courtney DM, Freund Y, Galipienzo J, Le Gal G, Ghanima W, Huisman MV, Kline JA, Moons KGM, Parpia S, Perrier A, Righini M, Robert-Ebadi H, Roy PM, Wells PS, de Wit K, van Smeden M, Geersing GJ. van Es N, et al. Among authors: le gal g. Eur Heart J. 2023 Aug 22;44(32):3073-3081. doi: 10.1093/eurheartj/ehad417. Eur Heart J. 2023. PMID: 37452732 Free PMC article.
The final model included age (in years), sex, previous VTE, recent surgery or immobilization, haemoptysis, cancer, clinical signs of deep vein thrombosis, inpatient status, D-dimer (in g/L), and an interaction term between age and D-dimer. The pooled c-statistic was 0.87 ( …
The final model included age (in years), sex, previous VTE, recent surgery or immobilization, haemoptysis, cancer, clinical signs of deep ve …
Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study.
Khan F, Coyle D, Thavorn K, van Katwyk S, Tritschler T, Hutton B, Le Gal G, Rodger MA, Fergusson DA. Khan F, et al. Among authors: le gal g. Ann Intern Med. 2023 Jul;176(7):949-960. doi: 10.7326/M22-3559. Epub 2023 Jun 27. Ann Intern Med. 2023. PMID: 37364263
DATA SOURCES: Systematic reviews and meta-analyses for the long-term risks and case-fatality rates of recurrent VTE and major bleeding. ...
DATA SOURCES: Systematic reviews and meta-analyses for the long-term risks and case-fatality rates of recurrent VTE and major bleedin …
Case-fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta-analysis.
Tritschler T, Patel A, Kraaijpoel N, Bhatt DL, De Luca G, Di Santo P, Feres F, Costa RA, Hibbert B, Isshiki T, Le Gal G, Castellucci LA. Tritschler T, et al. Among authors: le gal g. Res Pract Thromb Haemost. 2022 Nov 4;6(7):e12834. doi: 10.1002/rth2.12834. eCollection 2022 Oct. Res Pract Thromb Haemost. 2022. PMID: 36349260 Free PMC article.
The CFR of major bleeding was 10.8% (95% confidence interval [CI], 7.1-16.2; I (2) = 50%) in the entire study population, and 13.8% (95% CI, 6.5-27.1; I (2) = 28%), 11.2% (95% CI, 6.7-18.0; I (2) = 0%), and 5.8% (95% CI, 3.0-11.1; I (2) = 0%) in those on short-term (6 mont …
The CFR of major bleeding was 10.8% (95% confidence interval [CI], 7.1-16.2; I (2) = 50%) in the entire study population, and 13.8% (95% CI, …
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis.
Khan F, Rahman A, Tritschler T, Carrier M, Kearon C, Weitz JI, Schulman S, Couturaud F, Becattini C, Agnelli G, Brighton TA, Lensing AWA, Pinede L, Parpia S, Geersing GJ, Takada T, Bradbury CA, Andreozzi GM, Palareti G, Prandoni P, Buller HR, Mallick R, Hutton B, Thavorn K, Le Gal G, Rodger MA, Fergusson DA. Khan F, et al. Among authors: le gal g. Thromb Haemost. 2022 Jul;122(7):1186-1197. doi: 10.1055/a-1690-8728. Epub 2021 Nov 9. Thromb Haemost. 2022. PMID: 34753191
BACKGROUND: The long-term risk of major bleeding after discontinuing anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncertain. ...
BACKGROUND: The long-term risk of major bleeding after discontinuing anticoagulant therapy for a first unprovoked venous thromboembol …
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Khan F, Tritschler T, Kimpton M, Wells PS, Kearon C, Weitz JI, Büller HR, Raskob GE, Ageno W, Couturaud F, Prandoni P, Palareti G, Legnani C, Kyrle PA, Eichinger S, Eischer L, Becattini C, Agnelli G, Vedovati MC, Geersing GJ, Takada T, Cosmi B, Aujesky D, Marconi L, Palla A, Siragusa S, Bradbury CA, Parpia S, Mallick R, Lensing AWA, Gebel M, Grosso MA, Thavorn K, Hutton B, Le Gal G, Fergusson DA, Rodger MA; MAJESTIC Collaborators. Khan F, et al. Among authors: le gal g. Ann Intern Med. 2021 Oct;174(10):1420-1429. doi: 10.7326/M21-1094. Epub 2021 Sep 14. Ann Intern Med. 2021. PMID: 34516270
BACKGROUND: The long-term risk for major bleeding in patients receiving extended (beyond the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncertain. ...CONCLUSION: In patients with a first unprovoked VTE, the long-t …
BACKGROUND: The long-term risk for major bleeding in patients receiving extended (beyond the initial 3 to 6 months) anticoagulant the …
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
Khan F, Tritschler T, Kimpton M, Wells PS, Kearon C, Weitz JI, Büller HR, Raskob GE, Ageno W, Couturaud F, Prandoni P, Palareti G, Legnani C, Kyrle PA, Eichinger S, Eischer L, Becattini C, Agnelli G, Vedovati MC, Geersing GJ, Takada T, Cosmi B, Aujesky D, Marconi L, Palla A, Siragusa S, Bradbury CA, Parpia S, Mallick R, Lensing AWA, Gebel M, Grosso MA, Shi M, Thavorn K, Hutton B, Le Gal G, Rodger M, Fergusson D. Khan F, et al. Among authors: le gal g. J Thromb Haemost. 2021 Nov;19(11):2801-2813. doi: 10.1111/jth.15491. Epub 2021 Aug 22. J Thromb Haemost. 2021. PMID: 34379859 Free article.
BACKGROUND: The long-term risk for recurrent venous thromboembolism (VTE) during extended anticoagulation for a first unprovoked VTE is uncertain. ...CONCLUSIONS: In patients with a first unprovoked VTE, the long-term risk of recurrent VTE during extended anticoagul …
BACKGROUND: The long-term risk for recurrent venous thromboembolism (VTE) during extended anticoagulation for a first unprovoked VTE …
Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study.
Aziz D, Skeith L, Rodger MA, Sabri E, Righini M, Kovacs MJ, Carrier M, Kahn SR, Wells PS, Anderson DR, Chagnon I, Solymoss S, Crowther MA, White RH, Le Gal G. Aziz D, et al. Among authors: le gal g. J Thromb Haemost. 2021 Jun;19(6):1526-1532. doi: 10.1111/jth.15303. Epub 2021 Apr 21. J Thromb Haemost. 2021. PMID: 33724705 Free article.
INTRODUCTION: The risk of recurrent venous thromboembolism (VTE) after combined oral contraceptive (COC) use is variably reported. We assessed the long-term risk of recurrent VTE in women on COC at the time of a first VTE, in comparison to women without COC use. ...CONCLUS …
INTRODUCTION: The risk of recurrent venous thromboembolism (VTE) after combined oral contraceptive (COC) use is variably reported. We assess …
Protocol of changes induced by early Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (e-HABIT-ILE) in pre-school children with bilateral cerebral palsy: a multisite randomized controlled trial.
Araneda R, Sizonenko SV, Newman CJ, Dinomais M, Le Gal G, Ebner-Karestinos D, Paradis J, Klöcker A, Saussez G, Demas J, Bailly R, Bouvier S, Nowak E, Guzzetta A, Riquelme I, Brochard S, Bleyenheuft Y. Araneda R, et al. Among authors: le gal g. BMC Neurol. 2020 Jun 12;20(1):243. doi: 10.1186/s12883-020-01820-2. BMC Neurol. 2020. PMID: 32532249 Free PMC article.
In addition, this changes could demonstrated the impact of this intervention in the developmental curve of each child, improving functional ability, activity and participation in short-, mid- and long-term. NAME OF THE REGISTRY: Evaluation of Functional, Neuroplastic and B …
In addition, this changes could demonstrated the impact of this intervention in the developmental curve of each child, improving functional …
36 results